Reducing Asthma Disparities by Improving Provider-Patient Communication

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Johns Hopkins University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00181194
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The purpose of this study will be to assess the impact of a culturally-sensitive, patient-focused asthma communication instrument (ACCI) designed to enhance provider-patient communication by prompting and guiding providers in assessments of disease severity and discussion of adherence behaviors with minority patients with asthma.


Condition Intervention
Asthma
Device: Asthma Control and Communication Instrument

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Reducing Asthma Disparities by Improving Provider-Patient Communication About Asthma Severity and Adherence With Therapy

Resource links provided by NLM:


Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Accuracy of Provider Assessment of Asthma Severity
  • Accuracy of Clinician Assessment of Patient Adherence
  • Assessment of appropriateness of asthma treatment (consistency of care with asthma guidelines
  • Patient satisfaction with provider-patient communication and medical care

Secondary Outcome Measures:
  • These outcomes include indicators of poor asthma control such as health care service use for asthma exacerbations (unscheduled office visits, ER visits, hospitalizations) and use of oral corticosteroid and overuse of inhaled beta-agonist medications.

Estimated Enrollment: 350
Study Start Date: May 2005
Estimated Study Completion Date: December 2006
Detailed Description:

Improving communication between health care providers and their patients is the critical first step in efforts designed to reduce asthma-related health disparities in urban areas. Improving communication will help providers tailor asthma therapies to their patients’ needs, and help providers and patients to overcome barriers (e.g., concerns about adverse effects) to adherence with those asthma treatment plans.

  Eligibility

Ages Eligible for Study:   12 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • are able to provide informed consent;
  • report physician-diagnosed asthma;
  • report asthma symptoms and/or use of short-acting reliever medication at least twice weekly in the past month.

Exclusion Criteria:

  • state they do not have asthma;
  • have mild intermittent disease
  • no recent evidence of disease activity.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00181194

Contacts
Contact: Mayme Grant 410-550-2863 mgrant3@jhmi.edu
Contact: Cecilia Patino, MD 410-550-2618 cpatino2@jhmi.edu

Locations
United States, Maryland
Johns Hopkins Asthma And Allergy Center Recruiting
Baltimore, Maryland, United States, 21224
Contact: Mayme Grant    410-550-2863    mgrant3@jhmi.edu   
Contact: Cecilia Patino, MD    410-550-2618    cpatino2@jhmi.edu   
Principal Investigator: Gregory B Diette, MD, MHS         
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Gregory B Diette, MD, MHS Johns Hopkins Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00181194     History of Changes
Other Study ID Numbers: 20021855
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: United States: Institutional Review Board

Keywords provided by Johns Hopkins University:
Asthma

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on April 17, 2014